Skip to search formSkip to main contentSkip to account menu

hexocyclium

Known as: 4-(2-cyclohexyl-2-hydroxy-2-phenethyl)-1,1- dimethylpiperazinium, hexociclium 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Hexocyclium methylsulfate

Broader (1)

Piperazines
Poisoning by parasympatholytics (anticholinergics and antimuscarinics) and spasmolytics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
SCCS OPINION ON Dimethylpiperazinium Aminopyrazolopyridine HCl (A164)
SCCS The Committee shall provide Opinions on questions concerning all types of health and safety risks (notably chemical… 
2005
2005
Hexocyclium methosulfate in active duodenal ulcer
Summary and conclusionsA study of hexocyclium, a new anticholinergic drug, has been reported.1. After a control period… 
1984
1984
Comparative study of the cytoprotective effects of anticholinergic agents on the gastric mucosal lesions produced by intragastric administration of 0.6 M HCl in rats.
CFY strain rats (both sexes, 180-210 g) were fasted for 24 hr. Several anticholinergic agents atropine, oxyphencyclimine… 
1977
1977
Biopharmaceutic factors that influence effects of anticholinergic drugs: comparison of propantheline, hexocyclium, and isopropamide.
The antisecretory (determined from salivary flow rates) and antimotility (determined from riboflavin absorption) effects of… 
1966
1966
[Experiences in the treatment of hyperacid ulcer patients with Hexocyclium].
1958
1958
Hexocyclium (tral) in the treatment of peptic ulcer and its effect on human gastric secretion.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)